The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models.
Open accessAbstract
Cancer is a worldwide public health concern. Identifying carcinogens and limiting their exposure is one approach to the problem of reducing risk. Currently, epidemiology and rodent bioassays are the means by which putative human carcinogens are identified. Both methods have intrinsic limitations: they are slow and expensive processes with many uncertainties. The development of methods to modify specific genes in the mammalian genome has provided promising new tools for identifying carcinogens and characterizing risk. Transgenic mice may provide advantages in shortening the time required for bioassays and improving the accuracy of carcinogen identification; transgenic mice might now be included in the testing armamentarium without abandoning the two-year bioassay, the current standard. We show that mutagenic carcinogens can be identified with increased sensitivity and specificity using hemizygous p53 mice in which one allele of the p53 gene has been inactivated. Furthermore, the TG.AC transgenic model, carrying a v-Ha-ras construct, has developed papillomas and malignant tumors in response to a number of mutagenic and nonmutagenic carcinogens and tumor promoters, but not to noncarcinogens. We present a decision-tree approach that permits, at modest extra cost, the testing of more chemicals with improved ability to extrapolate from rodents to humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
Proteins regulating Ras and its relatives
Boguski, M. S., & McCormick, F. (1993) · Nature · doi:10.1038/366643a0 · Cited by 1,901
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., & Tlsty, T. D. (1992) · Cell · doi:10.1016/0092-8674(92)90243-6 · Cited by 1,332
Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., & Wahl, G. M. (1992) · Cell · doi:10.1016/0092-8674(92)90244-7 · Cited by 1,089
Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes
Stewart, T. A., Pattengale, P. K., & Leder, P. (1984) · Cell · doi:10.1016/0092-8674(84)90257-5 · Cited by 899
Prediction of Chemical Carcinogenicity in Rodents from in Vitro Genetic Toxicity Assays
Tennant, R. W., Margolin, B. H., Shelby, M. D., Zeiger, E., Haseman, J. K., Spalding, J., Caspary, W., Resnick, M., Stasiewicz, S., Anderson, B., et al. (1987) · Science · doi:10.1126/science.3554512 · Cited by 811
Self-citationDefects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells
Hartwell, L. (1992) · Cell · doi:10.1016/0092-8674(92)90586-2 · Cited by 770
Ashby, J., & Tennant, R. W. (1988) · Mutation Research/Genetic Toxicology · doi:10.1016/0165-1218(88)90114-0 · Cited by 733
Self-citationAshby, J., & Tennant, R. W. (1991) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(91)90003-e · Cited by 688
Self-citationSome Biological Aspects of Skin Carcinogenesis*
Boutwell, R. K. (2015) · Progress in Tumor Research · doi:10.1159/000385978 · Cited by 623
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.
Harvey, M., McArthur, M. J., Montgomery, C. A., Butel, J. S., Bradley, A., & Donehower, L. A. (1993) · Nature Genetics · doi:10.1038/ng1193-225 · Cited by 542
p53: At the Crossroads of Molecular Carcinogenesis and Risk Sssessment
Harris, C. C. (1993) · Science · doi:10.1126/science.8266092 · Cited by 475
Kemp, C. J., Donehower, L. A., Bradley, A., & Balmain, A. (1993) · Cell · doi:10.1016/0092-8674(93)90461-x · Cited by 457
A comparison of the biological activities of wild‐type and mutant p53
Zambetti, G. P., & Levine, A. J. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.10.8344485 · Cited by 413
Vogelstein, B. (1990) · Nature · doi:10.1038/348681a0 · Cited by 324
Leder, A., Kuo, A., Cardiff, R. D., Sinn, E., & Leder, P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9178 · Cited by 293
Genetic background alters the spectrum of tumors that develop in p53‐deficient mice
Harvey, M., McArthur, M. J., Montgomery, C. A., Bradley, A., & Donehower, L. A. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.10.8344491 · Cited by 285
Zeiger, E., Haseman, J. K., Shelby, M. D., Margolin, B. H., Tennant, R. W., & Holden, H. E. (1990) · Environmental and Molecular Mutagenesis · doi:10.1002/em.2850160502 · Cited by 230
Self-citationTennant, R. W., & Ashby, J. (1991) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(91)90002-d · Cited by 226
Self-citationHaseman, J. K., Huff, J. E., Rao, G. N., Arnold, J. E., Boorman, G. A., & McConnell, E. E. (1985) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/75.5.975 · Cited by 168
Information value of the rodent bioassay
Lave, L. B., Ennever, F. K., Rosenkranz, H. S., & Omenn, G. S. (1988) · Nature · doi:10.1038/336631a0 · Cited by 126
Scientific Concepts, Value, And Significance Of Chemical Carcinogenesis Studies
Huff, J. E., HASEMAN, J., & Rall, D. P. (1991) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.31.040191.003201 · Cited by 113
Stoler, A. B., Stenbäck, F., & Balmain, A. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.5.1103 · Cited by 85
Frederick, C. B., Potter, D. W., Chang-Mateu, M. I., & Andersen, M. E. (1992) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(92)90075-4 · Cited by 83
Stratification of rodent carcinogenicity bioassay results to reflect relative human hazard
Tennant, R. W. (1993) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(93)90006-2 · Cited by 81
Self-citationCharacterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice
Hegi, M. E., Söderkvist, P., Foley, J. F., Schoonhoven, R., Swenberg, J. A., Kari, F. W., Maronpot, R. R., Anderson, M. W., & Wiseman, R. W. (1993) · Carcinogenesis · doi:10.1093/carcin/14.5.803 · Cited by 80
Transgenic Animal Models for Measuring MutationsIn Vivo
Mirsalis, J. C., Monforte, J., & Winegar, R. A. (1994) · Critical Reviews in Toxicology · doi:10.3109/10408449409021608 · Cited by 78
Morrison, V. M., & Ashby, J. (1994) · Mutagenesis · doi:10.1093/mutage/9.4.367 · Cited by 73
Jerry, D. J., Butel, J. S., Donehower, L. A., Paulson, E. J., Cochran, C., Wiseman, R. W., & Medina, D. (1994) · Molecular Carcinogenesis · doi:10.1002/mc.2940090309 · Cited by 57
Focal transgene expression associated with papilloma development in v‐Ha‐ras–transgenic TG.AC mice
Hansen, L. A., & Tennant, R. W. (1994) · Molecular Carcinogenesis · doi:10.1002/mc.2940090306 · Cited by 56
Self-citationMultiple-Site Carcinogenicity of Benzene in Fischer 344 Rats and B6C3F 1 Mice
Huff, J. E., Haseman, J. K., DeMarini, D. M., Eustis, S. L., Maronpot, R. R., Peters, A. C., Persing, R. L., Chrisp, C. E., & Jacobs, A. C. (1989) · Environmental Health Perspectives · doi:10.2307/3430769 · Cited by 50
Bioassay of p-cresidine for possible carcinogenicity.
(1979) · PubMed · Cited by 16
Cited by
When NRF2 Talks, Who's Listening?
Wakabayashi, N., Slocum, S. L., Skoko, J. J., Shin, S., & Kensler, T. W. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3216 · Cited by 595
“This interaction is not unexpected, as when either the cytoprotective response system of NRF2, or p53, a cell-fate decision molecule is removed, the incidence of cancer increases after carcinogen challenge (117, 146).”
Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010
Adler, S., Basketter, D., Creton, S., Pelkonen, O., van Benthem, J., Zuang, V., Andersen, K. E., Angers-Loustau, A., Aptula, A., Bal-Price, A., et al. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0693-2 · Cited by 584
Lymphomas in Eμ-Pim1 Transgenic Mice Exposed to Pulsed 900 MHz Electromagnetic Fields
Repacholi, M. H., Basten, A., Gebski, V., Noonan, D., Finnie, J., & Harris, A. W. (1997) · Radiation Research · doi:10.2307/3579630 · Cited by 400
Drinking water disinfection byproducts: review and approach to toxicity evaluation.
Boorman, G. A. (1999) · Environmental Health Perspectives · doi:10.1289/ehp.99107s1207 · Cited by 373
Magnuson, B. A., Burdock, G. A., Doull, J., Kroes, R. M., Marsh, G. M., Pariza, M. W., Spencer, P. S., Waddell, W. J., Walker, R., & Williams, G. M. (2007) · Critical Reviews in Toxicology · doi:10.1080/10408440701516184 · Cited by 353
Metadata
- Authors
- Tennant, R. W., French, J. E., & Spalding, J. W.
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 1995-10
- Volume
- 103
- Issue
- 10
- Pages
- 942-950
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- OpenAlex
- W1974958661
- Cited by
- 261
- References
- 37
- FWCI
- 9.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.